Novartis AG (NYSE:NVS) released new data Wednesday from the ALITHIOS open-label extension study. Data show first-line ...

HOUSTON — Bruton's tyrosine kinase inhibitors such as ibrutinib, acalabrutinib, and zanubrutinib have revolutionized the ...

The decision to discontinue BTK inhibitor treatment for CLL is complex, with emerging data suggesting that time-limited ...

One rival to Imjudo/Imfinzi in previously untreated HCC is Roche's dual regimen of PD-L1 inhibitor Tecentriq (atezolizumab) and CD20-targeting antibody Avastin (bevacizumab), which was approved by ...

Richter transformation involves the evolution of chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) into an ...

Susac syndrome is a rare inflammatory vascular endotheliopathy affecting the small vessels of the brain, eye, and ear.1,2 ...

The recently published article in Science by the Genentech team presents the structure of CD20 in complex with the therapeutic monoclonal antibody RTX. This study underscores the significance of ...

In addition, some antibodies bind to different epitopes of CD20, which may yield different ... are also of interest. The mTOR inhibitor temsirolimus is active in refractory MCL, with a 38% ...

Richter transformation describes the development of an aggressive lymphoma in patients with chronic lymphocytic leukaemia, ...

The company also has other products in its portfolio, including Umbralisib, an oral inhibitor for certain lymphomas ... a newly FDA-approved anti-CD20 monoclonal antibody, targets specific ...